AI assistant
Sending…
DEXCOM INC — Director's Dealing 2015
Dec 2, 2015
30198_dirs_2015-12-02_12205c85-b13f-4e93-91b7-0951e1120c68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-11-30
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-30 | Common Stock | M | 5000.0 | $6.85 | Acquired | 464018 | Direct |
| 2015-11-30 | Common Stock | S | 5000.0 | $86.5 | Disposed | 459018 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-30 | Non-Qualified Stock Option (right to buy) | $6.85 | M | 5000.0 | Disposed | 2017-06-19 | Common Stock (5000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
| Common Stock | 316064 | Indirect |
Footnotes
F1: Included in this number are 136,564 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 81,251 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 20,313 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17